GSK consumer spin-off will create a major player in a sector ripe for consolidation

GlaxoSmithKline products

With so much focus on the remaining pharma business it’s been somewhat overlooked what a significant company the new consumer business will be.

Already have an account? Sign in here

Want access to this article?

Register for LIMITED access

REGISTER FOR FREE

Get PREMIUM access for £1 a week

SUBSCRIBE NOW